Neurexin I rabbit pAb
ENT-A7694
Description
| REF | ENT-A7694 |
|---|---|
| Category | Antibody Polyclonal |
| Description | Neurexin I rabbit pAb |
| Source | Rabbit |
| Applications | WB;IHC |
| Reactivity | Human;Mouse;Rat |
| Reactivity | Human;Mouse;Rat |
| Dilution | WB 1:500-2000;IHC-p 1:50-300 |
| Immunogen | The antiserum was produced against synthesized peptide derived from human NRXN1. AA range:502-551 |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | 150kD |
| Human Gene ID | 9378 |
| Human Swiss Prot Nº | Q9ULB1 |
| Subcellular Location | Cell junction, synapse, presynaptic cell membrane ; Single-pass type I membrane protein . |
Other Name: NRXN1; KIAA0578; Neurexin-1-alpha; Neurexin I-alpha
Background: NRXN1 (neurexin 1) encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for NRXN1 in the 3′ region. Mutations in NRXN1 are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia.
